Gene: MAP2K3

5606
MAPKK3|MEK3|MKK3|PRKMK3|SAPKK-2|SAPKK2
mitogen-activated protein kinase kinase 3
protein-coding
17p11.2
Ensembl:ENSG00000034152 MIM:602315 Vega:OTTHUMG00000134322 UniprotKB:P46734
NG_028256.1
PubMed
0   ANCO-SNPs
ND
3   
NA (AD)  NA (ND)   (Frontal_Cortex)
2.219e-1 (AD)  9.502e-1 (ND)

DNA Methylation

There is no related methylation information for this gene.

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
STK400.851
NKIRAS20.834
FRMD80.83
AEN0.819
ITPKC0.819
SOD20.803
CLCF10.802
SHC10.801
RELB0.801
TEAD40.797

Top 10 negatively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
OR4F5-0.404
OR4F29-0.378
HAPLN1-0.274
EDN3-0.272
ACY3-0.256
GPR17-0.251
PDE11A-0.25
CASC15-0.249
LYPD8-0.239
SNX22-0.238

Drugs/Compounds

    There is no DrugBank record for this gene !

ID Drug Name Action PubMed
C5321622-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine"[PIK3CA gene mutant form results in increased susceptibility to 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine] which results in decreased expression of MAP2K3 mRNA"20453058
C0939732-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [arsenic trioxide results in increased phosphorylation of and results in increased activity of MAP2K3 protein]20615082
C0859112-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [1-Methyl-4-phenylpyridinium affects the expression of MAP2K3 mRNA]12710931
C0235142,6-dinitrotoluene"2,6-dinitrotoluene affects the expression of MAP2K3 mRNA"21346803
D000082AcetaminophenAcetaminophen results in increased expression of MAP2K3 mRNA29067470
D000082AcetaminophenAcetaminophen affects the expression of MAP2K3 mRNA17562736
D000111AcetylcysteineAcetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAP2K3 protein]18703135
D000111AcetylcysteineAcetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAP2K3 protein]18703135
C016601afimoxifeneMAP2K3 results in decreased susceptibility to afimoxifene21233418
D016604Aflatoxin B1Aflatoxin B1 results in decreased methylation of MAP2K3 gene27153756
D016604Aflatoxin B1Aflatoxin B1 results in decreased expression of MAP2K3 mRNA19770486
C103505AM 251AM 251 results in decreased expression of MAP2K3 mRNA16500647
C030325anthrax toxinanthrax toxin results in increased cleavage of MAP2K3 protein24337744
C006632arsenic trioxide2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [arsenic trioxide results in increased phosphorylation of and results in increased activity of MAP2K3 protein]20615082
C006632arsenic trioxidearsenic trioxide results in increased phosphorylation of and results in increased activity of MAP2K3 protein16818652
C006632arsenic trioxideMAP2K3 protein affects the susceptibility to arsenic trioxide16818652
C006632arsenic trioxideMAP2K3 protein promotes the reaction [arsenic trioxide results in increased phosphorylation of and results in increased activity of MAPK14 protein]16818652
C015001arsenitearsenite results in increased expression of MAP2K3 mRNA18191166
D017638Asbestos, Crocidolite"Asbestos, Crocidolite affects the expression of MAP2K3 mRNA"17331233
D017638Asbestos, Crocidolite"Asbestos, Crocidolite results in increased expression of MAP2K3 mRNA"18687144
D001205Ascorbic AcidAscorbic Acid inhibits the reaction [Fenretinide results in increased phosphorylation of MAP2K3 protein]16407847
C406592azaspiracidazaspiracid results in decreased expression of MAP2K3 mRNA28939011
C550990baicalein-7-O-diglucosidebaicalein-7-O-diglucoside results in increased expression of MAP2K3 mRNA26253462
C550990baicalein-7-O-diglucosidebaicalein-7-O-diglucoside results in increased expression of MAP2K3 protein26253462
C550990baicalein-7-O-diglucosidebaicalein-7-O-diglucoside results in increased expression of MAP2K3 protein modified form26253462
D001564Benzo(a)pyreneBenzo(a)pyrene results in increased expression of MAP2K3 mRNA19770486
D0151237,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MAP2K3 mRNA"19150397
D004958EstradiolEstradiol results in decreased expression of MAP2K3 mRNA23094148
D004958EstradiolEstradiol affects the expression of MAP2K3 mRNA15598610
C483161beta-hydroxy simvastatin acidbeta-hydroxy simvastatin acid results in decreased expression of MAP2K3 mRNA18192240
C006780bisphenol Abisphenol A results in decreased expression of MAP2K3 mRNA29275510
C006780bisphenol A[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of MAP2K3 mRNA28628672
C006780bisphenol Abisphenol A results in increased expression of MAP2K3 mRNA26996129
C006780bisphenol Abisphenol A results in increased expression of MAP2K3 protein26996129
C006780bisphenol AMAP2K3 protein inhibits the reaction [MIR21A mRNA inhibits the reaction [bisphenol A results in increased expression of ADIPOQ mRNA]]26996129
C006780bisphenol AMAP2K3 protein inhibits the reaction [MIR21A mRNA inhibits the reaction [bisphenol A results in increased expression of ADIPOQ protein]]26996129
C006780bisphenol AMAP2K3 protein inhibits the reaction [MIR21A mRNA inhibits the reaction [bisphenol A results in increased expression of CEBPA mRNA]]26996129
C006780bisphenol AMAP2K3 protein inhibits the reaction [MIR21A mRNA inhibits the reaction [bisphenol A results in increased expression of CEBPA protein]]26996129
C006780bisphenol AMAP2K3 protein inhibits the reaction [MIR21A mRNA inhibits the reaction [bisphenol A results in increased expression of PPARG mRNA]]26996129
C006780bisphenol AMAP2K3 protein inhibits the reaction [MIR21A mRNA inhibits the reaction [bisphenol A results in increased expression of PPARG protein]]26996129
C006780bisphenol AMIR21A mRNA affects the reaction [bisphenol A results in increased expression of MAP2K3 protein]26996129
C006780bisphenol Abisphenol A affects the expression of MAP2K3 mRNA25181051
D020122tert-Butylhydroperoxidetert-Butylhydroperoxide results in increased expression of MAP2K3 mRNA15336504
D020122tert-Butylhydroperoxidetert-Butylhydroperoxide results in increased phosphorylation of MAP2K3 protein17003459
C018475butyraldehydebutyraldehyde results in increased expression of MAP2K3 mRNA26079696
D019256Cadmium ChlorideAcetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAP2K3 protein]18703135
D019256Cadmium ChlorideCadmium Chloride results in increased expression of MAP2K3 mRNA12160620
D019256Cadmium ChlorideCadmium Chloride results in increased phosphorylation of MAP2K3 protein18703135
D019256Cadmium ChlorideAcetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAP2K3 protein]18703135
D019256Cadmium ChlorideCadmium Chloride results in increased phosphorylation of MAP2K3 protein18021293|1870313
D002166CamptothecinCamptothecin results in increased expression of MAP2K3 mRNA17374387
D002220CarbamazepineCarbamazepine affects the expression of MAP2K3 mRNA24752500
C503589cis-9, trans-11-conjugated linoleic acid"[cis-9, trans-11-conjugated linoleic acid co-treated with trans-10,cis-12-conjugated linoleic acid] results in increased phosphorylation of and results in increased activity of MAP2K3 protein"17869086
C503589cis-9, trans-11-conjugated linoleic acid"cis-9, trans-11-conjugated linoleic acid results in increased phosphorylation of and results in increased activity of MAP2K3 protein"17869086
D002994ClofibrateClofibrate results in decreased expression of MAP2K3 mRNA16081524
D002995Clofibric Acid[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of MAP2K3 mRNA17602206
C018021cobaltous chloridecobaltous chloride results in increased expression of MAP2K3 mRNA24386269
D003300Copper[Disulfiram binds to Copper] which results in decreased expression of MAP2K3 mRNA24690739
D003375CoumestrolCoumestrol results in decreased expression of MAP2K3 mRNA19167446
D003474CurcuminCurcumin results in increased expression of MAP2K3 mRNA15713895
D016572CyclosporineCyclosporine results in decreased expression of MAP2K3 mRNA20106945
D003630DaunorubicinDaunorubicin results in increased expression of MAP2K3 mRNA17374387
C029415deacylcortivazoldeacylcortivazol results in increased expression of MAP2K3 mRNA15817653
D003907DexamethasoneDexamethasone results in increased expression of MAP2K3 mRNA15817653
D003907Dexamethasone[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of MAP2K3 mRNA28628672
D003993Dibutyl PhthalateDibutyl Phthalate results in decreased expression of MAP2K3 mRNA21266533
D002945Cisplatin[Cisplatin co-treated with jinfukang] results in decreased expression of MAP2K3 mRNA27392435
D002945CisplatinMAP2K3 results in increased susceptibility to Cisplatin22164285
D004008DiclofenacDiclofenac affects the expression of MAP2K3 mRNA24752500
C000944dicrotophosdicrotophos results in increased expression of MAP2K3 mRNA28302478
D004052Diethylnitrosamine[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of MAP2K3 mRNA17602206
C051904dinophysistoxin 1dinophysistoxin 1 results in increased expression of MAP2K3 mRNA28939011
D004221Disulfiram[Disulfiram binds to Copper] which results in decreased expression of MAP2K3 mRNA24690739
D004317DoxorubicinDoxorubicin affects the activity of MAP2K3 protein15870702
D000431EthanolEthanol results in increased expression of MAP2K3 mRNA20655511
D005047EtoposideEtoposide results in increased expression of MAP2K3 mRNA17374387
D005485FlutamideFlutamide results in increased expression of MAP2K3 mRNA24136188
C070081fulvestrantMAP2K3 promotes the reaction [fulvestrant results in decreased expression of GJA1 protein]29180066
C056507gemcitabinegemcitabine results in increased phosphorylation of MAP2K3 protein15003513
D019833GenisteinGenistein results in decreased expression of MAP2K3 mRNA16705744
D005839GentamicinsGentamicins results in decreased expression of MAP2K3 mRNA22061828
D005897GlafenineGlafenine results in decreased expression of MAP2K3 mRNA24136188
D017313FenretinideAscorbic Acid inhibits the reaction [Fenretinide results in increased phosphorylation of MAP2K3 protein]16407847
D017313FenretinideFenretinide results in increased phosphorylation of MAP2K3 protein16407847
D006830Hydralazine[Hydralazine co-treated with Valproic Acid] results in increased expression of MAP2K3 mRNA17183730
C492448ICG 001ICG 001 results in decreased expression of MAP2K3 mRNA26191083
D007213Indomethacin[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of MAP2K3 mRNA28628672
D015759Ionomycin[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of MAP2K3 mRNA25613284
D0150561-Methyl-3-isobutylxanthine[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of MAP2K3 mRNA28628672
C544151jinfukang[Cisplatin co-treated with jinfukang] results in decreased expression of MAP2K3 mRNA27392435
D008070LipopolysaccharidesMAP2K3 protein mutant form inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]18209571
D008070LipopolysaccharidesIRAK2 protein promotes the reaction [Lipopolysaccharides results in increased activity of MAP2K3 protein]21291324
D008070LipopolysaccharidesLipopolysaccharides results in increased activity of MAP2K3 protein21291324
C025340manganese chloridemanganese chloride results in decreased methylation of MAP2K3 gene27913844
D008694MethamphetamineMethamphetamine results in increased expression of MAP2K3 mRNA19564919
D008727MethotrexateMethotrexate results in decreased expression of MAP2K3 mRNA24449571
D008727MethotrexateMethotrexate results in increased expression of MAP2K3 mRNA21678067
D008748MethylcholanthreneMethylcholanthrene results in increased expression of MAP2K3 mRNA20713471
D0156551-Methyl-4-phenylpyridinium2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [1-Methyl-4-phenylpyridinium affects the expression of MAP2K3 mRNA]12710931
D009151Mustard GasMustard Gas results in increased phosphorylation of MAP2K3 protein15251176
C044361M-VAC protocolMAP2K3 protein results in decreased susceptibility to M-VAC protocol15814643
C583365N-(2-(1,1'-bicyclopropyl)-2-ylphenyl)-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide"N-(2-(1,1'-bicyclopropyl)-2-ylphenyl)-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide results in increased expression of MAP2K3 mRNA"29244179
D037742Nanotubes, Carbon"Nanotubes, Carbon analog results in increased expression of MAP2K3 mRNA"25554681
D0150581-Naphthylisothiocyanate1-Naphthylisothiocyanate results in increased expression of MAP2K3 mRNA20551477
C051752nefazodonenefazodone results in increased expression of MAP2K3 mRNA24136188
C022838nickel chlorideGADD45A protein inhibits the reaction [nickel chloride results in increased activity of MAP2K3 protein]23536762
C012655nimesulidenimesulide results in increased expression of MAP2K3 mRNA24136188
C025256nonylphenolnonylphenol results in increased expression of MAP2K3 protein24039973
C464660obeticholic acidobeticholic acid results in decreased expression of MAP2K3 mRNA27939613
D019319Okadaic AcidOkadaic Acid results in increased expression of MAP2K3 mRNA28939011
D010269ParaquatMAP2K3 gene mutant form results in decreased susceptibility to Paraquat17324951
C568608PCI 5002[PCI 5002 co-treated with Zinc] results in increased expression of MAP2K3 mRNA18593933
C076994perfluorooctane sulfonic acidperfluorooctane sulfonic acid results in decreased expression of MAP2K3 mRNA26300304
C006253pirinixic acidpirinixic acid results in decreased expression of MAP2K3 mRNA20813756|2381119
D011794QuercetinQuercetin results in increased expression of MAP2K3 mRNA21632981
D020849Raloxifene Hydrochloride[Raloxifene Hydrochloride co-treated with ESR2 protein] results in increased expression of MAP2K3 mRNA19059307
C059514resveratrolresveratrol results in increased expression of MAP2K3 protein25505154
C059514resveratrolresveratrol affects the expression of MAP2K3 mRNA15748624
D012643SeleniumSelenium results in increased expression of MAP2K3 mRNA19244175
C009250sevofluranesevoflurane results in increased phosphorylation of MAP2K3 protein18349187
D012822Silicon DioxideSilicon Dioxide analog results in increased expression of MAP2K3 mRNA25895662
D012822Silicon DioxideSilicon Dioxide results in increased expression of MAP2K3 mRNA25351596
C017947sodium arsenitesodium arsenite results in increased expression of MAP2K3 mRNA12760830
C017947sodium arsenitesodium arsenite results in decreased expression of MAP2K3 mRNA19822182
D053260SootSoot results in increased expression of MAP2K3 mRNA26551751
D014284TriiodothyronineTriiodothyronine results in increased expression of MAP2K3 mRNA17403546
D013629Tamoxifen[Tamoxifen co-treated with ESR2 protein] results in increased expression of MAP2K3 mRNA19059307
C020806tetrabromobisphenol Atetrabromobisphenol A affects the expression of MAP2K3 mRNA18976794
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin affects the expression of MAP2K3 mRNA21570461
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in increased expression of MAP2K3 mRNA18796159
D013755Tetradecanoylphorbol Acetate[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of MAP2K3 mRNA25613284
D013974ThyroxineThyroxine results in decreased expression of MAP2K3 mRNA17403546
D014028Tobacco Smoke PollutionTobacco Smoke Pollution results in increased expression of MAP2K3 mRNA28065790
D014118Toxins, Biological"Toxins, Biological affects the expression of MAP2K3 mRNA"19682533
C496197trans-10,cis-12-conjugated linoleic acid"[cis-9, trans-11-conjugated linoleic acid co-treated with trans-10,cis-12-conjugated linoleic acid] results in increased phosphorylation of and results in increased activity of MAP2K3 protein"17869086
C011559tributyltintributyltin results in decreased expression of MAP2K3 mRNA27678064
C015559trimellitic anhydridetrimellitic anhydride results in increased expression of MAP2K3 mRNA19042947
C016805tris(1,3-dichloro-2-propyl)phosphate"tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of MAP2K3 mRNA"26179874
C057693troglitazoneMAP2K3 protein affects the reaction [troglitazone results in increased expression of GADD45A mRNA]15064713
D014520UrethaneUrethane results in increased expression of MAP2K3 mRNA28818685
D014635Valproic Acid[Hydralazine co-treated with Valproic Acid] results in increased expression of MAP2K3 mRNA17183730
D014635Valproic AcidValproic Acid results in decreased methylation of MAP2K3 gene29154799
D014635Valproic AcidValproic Acid results in increased expression of MAP2K3 mRNA23179753|2800136
C025643vinclozolinvinclozolin affects the expression of MAP2K3 mRNA19015723
D014873Water PollutantsWater Pollutants results in increased expression of MAP2K3 mRNA23591932
D015032Zinc[PCI 5002 co-treated with Zinc] results in increased expression of MAP2K3 mRNA18593933

GO/Pathway

GO ID GO Term Qualifier Evidence PubMed
GO:0004674protein serine/threonine kinase activity-IBA21873635  
GO:0004708MAP kinase kinase activity-IBA21873635  
GO:0004708MAP kinase kinase activity-IEA-  
GO:0004713protein tyrosine kinase activity-IEA-  
GO:0005515protein binding-IPI11980910  17255949  19805025  20067578  20173330  21044950  
21771788  23602568  
GO:0005524ATP binding-IEA-  
GO:0019901protein kinase binding-IPI11279118  
GO ID GO Term Qualifier Evidence PubMed
GO:0000187activation of MAPK activity-IBA21873635  
GO:0000187activation of MAPK activity-TAS-  
GO:0006954inflammatory response-IEA-  
GO:0007165signal transduction-TAS7839144  
GO:0007346regulation of mitotic cell cycle-IBA21873635  
GO:0018108peptidyl-tyrosine phosphorylation-IEA-  
GO:0023014signal transduction by protein phosphorylation-IBA21873635  
GO:0032147activation of protein kinase activity-IBA21873635  
GO:0035924cellular response to vascular endothelial growth factor stimulus-IMP22696064  
GO:0038066p38MAPK cascade-IMP22696064  
GO:0042035regulation of cytokine biosynthetic process-IEA-  
GO:0043536positive regulation of blood vessel endothelial cell migration-IMP22696064  
GO:0045860positive regulation of protein kinase activity-IDA11980910  
GO:0045893positive regulation of transcription, DNA-templated-IDA11980910  
GO:0060048cardiac muscle contraction-IEA-  
GO ID GO Term Qualifier Evidence PubMed
GO:0005654nucleoplasm-TAS-  
GO:0005737cytoplasm-IBA21873635  
GO:0005829cytosol-TAS-  
GO:0016020membrane-HDA19946888  
KEGG ID KEGG Term
hsa04010MAPK signaling pathway
hsa04620Toll-like receptor signaling pathway
hsa04664Fc epsilon RI signaling pathway
hsa04912GnRH signaling pathway
hsa05014Amyotrophic lateral sclerosis (ALS)
hsa05145Toxoplasmosis
Reactome ID Reactome Term Evidence
R-HSA-1280215Cytokine Signaling in Immune systemTAS
R-HSA-1643685DiseaseTAS
R-HSA-166016Toll Like Receptor 4 (TLR4) CascadeTAS
R-HSA-166058MyD88:Mal cascade initiated on plasma membraneTAS
R-HSA-166166MyD88-independent TLR4 cascade TAS
R-HSA-168138Toll Like Receptor 9 (TLR9) CascadeTAS
R-HSA-168142Toll Like Receptor 10 (TLR10) CascadeTAS
R-HSA-168164Toll Like Receptor 3 (TLR3) CascadeTAS
R-HSA-168176Toll Like Receptor 5 (TLR5) CascadeTAS
R-HSA-168179Toll Like Receptor TLR1:TLR2 CascadeTAS
R-HSA-168181Toll Like Receptor 7/8 (TLR7/8) CascadeTAS
R-HSA-168188Toll Like Receptor TLR6:TLR2 CascadeTAS
R-HSA-168249Innate Immune SystemTAS
R-HSA-168256Immune SystemTAS
R-HSA-168898Toll-Like Receptors CascadesTAS
R-HSA-181438Toll Like Receptor 2 (TLR2) CascadeTAS
R-HSA-2262752Cellular responses to stressTAS
R-HSA-2559580Oxidative Stress Induced SenescenceTAS
R-HSA-2559583Cellular SenescenceTAS
R-HSA-448424Interleukin-17 signalingTAS
R-HSA-449147Signaling by InterleukinsTAS
R-HSA-450294MAP kinase activationTAS
R-HSA-450302activated TAK1 mediates p38 MAPK activationTAS
R-HSA-5210891Uptake and function of anthrax toxinsTAS
R-HSA-5339562Uptake and actions of bacterial toxinsTAS
R-HSA-5663205Infectious diseaseTAS
R-HSA-8953897Cellular responses to external stimuliTAS
R-HSA-937061TRIF(TICAM1)-mediated TLR4 signaling TAS
R-HSA-975138TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activationTAS
R-HSA-975155MyD88 dependent cascade initiated on endosomeTAS
R-HSA-975871MyD88 cascade initiated on plasma membraneTAS

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID Title (Year) Author Journal
26230583Differential Gene Expression in Colon Tissue Associated With Diet, Lifestyle, and Related Oxidative Stress. (2015)Slattery MLPLoS One
29762635An Epigenome-Wide Association Study (EWAS) of Obesity-Related Traits. (2018 May 14)Dhana KAm J Epidemiol
23414319Combined influence of gene-specific cord blood methylation and maternal smoking habit on birth weight. (2013 Feb)Haworth KEEpigenomics